FNDC5 and Cognitive impairment: Thus, our study revealed that through regulating microglial activation, FNDC5/irisin improved the II/R-induced neuroinflammation, oxidative stress, and neuronal loss, which further improved cognitive deficits, a newly discovered potential therapeutic target.